https://doi.org/10.7490/f1000research.1119649.1
Poster
NOT PEER REVIEWED
Download
metrics
VIEWS
152
 
downloads
4
CITE
How to cite this poster:
Chávez-Domínguez RL, Aguilar-Cazares D, Prado-García H et al. Study of immunogenic cell death markers in lung adenocarcinoma cell lines treated with therapeutic agents [version 1; not peer reviewed]. F1000Research 2023, 12:1399 (poster) (https://doi.org/10.7490/f1000research.1119649.1)
NOTE: it is important to ensure the information in square brackets after the title is included in this citation.

Study of immunogenic cell death markers in lung adenocarcinoma cell lines treated with therapeutic agents

Rodolfo L Chávez-Domínguez1, Dolores Aguilar-Cazares, H Prado-García, Lorenzo Islas-Vazquez, Jose S. Lopez-Gonzalez
Author Affiliations
  • Metrics
  • 152 Views
  • 4 Downloads
 
Part of the gateway
Browse by related subjects
Published 23 Oct 2023

Study of immunogenic cell death markers in lung adenocarcinoma cell lines treated with therapeutic agents

[version 1; not peer reviewed]

Rodolfo L Chávez-Domínguez1, Dolores Aguilar-Cazares, H Prado-García, Lorenzo Islas-Vazquez, Jose S. Lopez-Gonzalez
Author Affiliations
1 Universidad Nacional Autonoma de Mexico, Posgrado en Ciencias Biologicas, Not Applicable, Ciudad de Mexico, Mexico
Presented at
Immunotherapy of Cancer Conference (ITOC), 2017
Abstract
Competing Interests

No competing interests were disclosed

Keywords
lung cancer, adenocarcinoma, chemotherapy, cisplatin, TKI, immunogenic cell death
Comments
0 Comments
 
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.